AngioDynamics
ANGO
120 hedge funds and large institutions have $366M invested in AngioDynamics in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 54 increasing their positions, 25 reducing their positions, and 10 closing their positions.
116% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 25
21% more capital invested
Capital invested by funds: $302M → $366M (+$64.1M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
1% less funds holding
Funds holding: 121 → 120 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$13.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.52M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.33M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$1.23M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$3.36M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$2.99M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$2.73M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.71M |
| 5 |
Millennium Management
New York
|
-$1.2M |
ANGO Hedge Fund Activity: Q2 2016 in Review
120 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2016, worth a combined $366M — up 21% from $302M a quarter earlier.
Fund positioning in ANGO was balanced in Q2 2016: 10 funds opened new positions, 10 closed out, 54 added to existing stakes and 25 trimmed.
The largest buyer was Broadfin Capital, adding an estimated $13.9M. The largest seller was First Light Asset Management, exiting entirely with an estimated $3.36M sold.
- 120 institutional investors held AngioDynamics (ANGO) as of Q2 2016, down from 121 in Q1 2016.
- Funds reported $366M of AngioDynamics stock for Q2 2016, up 21% quarter-over-quarter.
- 10 funds opened new AngioDynamics positions in Q2 2016 and 10 closed out, a net change of 0 holders.
- The largest AngioDynamics buyer in Q2 2016 was Broadfin Capital, an estimated $13.9M added.
- The largest AngioDynamics seller in Q2 2016 was First Light Asset Management, an estimated $3.36M sold.
Based on aggregated 13F filings for Q2 2016.